Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DAREthis companyDare Bioscience, Inc.	$0.66	-1.61×	75.9×	209.43×	-18.58×	-72.9%	-137.5%	-1315.5%	-1300.7%	-471.4%	-124.5%	-4.8%	0.93×	2.12×	-16.47×	1.14×	0.0%	2	-13.47	2	C+
AIMDAinos, Inc.	$0.64	-0.47×	0.93×	56.41×	-1.9×	-536.9%	-3767.2%	-11268.3%	-11897.0%	-195.3%	-70.7%	-66.4%	1.45×	-1.14×	-19.65×	1.06×	0.0%	2	-8.34	1	D+
ASBPAspire Biopharma Holdings, Inc.	$8.45	-9.67×	-37.14×	38,181.4×	-20.93×	-107.4%	-1.9%	-312016.9%	-394725.1%	383.9%	395.3%	-2.1%	-0.22×	-0.03×	-2.27×	0.17×	0.0%	5	-3.49	2	C
CTXRCitius Pharmaceuticals, Inc.	$0.55	-0.37×	0.2×	0×	-0.3×	64.2%	0.0%	0.0%	0.0%	-55.4%	-44.2%	-193.5%	0.03×	0.06×	-143.87×	0.62×	0.0%	3	-4.03	2	B-
FBLGFibroBiologics, Inc. Common Stock	$0.97	-0.54×	1.63×	0×	-0.43×	-21.2%	0.0%	0.0%	0.0%	-302.9%	-194.4%	-165.8%	0.39×	0.14×	-81.61×	3.61×	0.0%	2	-16.92	2	B-
PALIPalisade Bio, Inc.	$1.23	-7.83×	1.01×	0×	0.15×	113.1%	0.0%	0.0%	0.0%	-13.0%	-13.9%	-8.3%	0×	7.95×	-1,805.6×	28.95×	0.0%	4	19.43	2	C
Peer median	—	-0.54×	0.93×	0×	-0.43×	-21.2%	0.0%	0.0%	0.0%	-55.4%	-44.2%	-66.4%	0.03×	0.06×	-81.61×	1.06×	0.0%	3	-4.03	2	—